Respiratory Syncytial Virus (RSV) Infection Overview

Save information for later
Sign Up

Learn About Respiratory Syncytial Virus (RSV) Infection

What is the definition of Respiratory Syncytial Virus (RSV) Infection?
Respiratory syncytial virus (RSV) is a common virus that causes infections of the respiratory tract and lungs. Respiratory syncytial virus mostly affects children but can also infect adults.
What are the symptoms of Respiratory Syncytial Virus (RSV) Infection?
Symptoms of respiratory syncytial virus can be similar to a mild cold in older, healthy children and adults. In babies under 12 months, premature infants, individuals with heart or lung disease, immunocompromised individuals, older adults, and individuals with other serious medical problems, respiratory syncytial virus can cause severe infection. Symptoms of respiratory syncytial virus infection usually appear within 4-to-6 days after infection. Symptoms of respiratory syncytial virus infection include decreased appetite, runny nose, congestion, cough, sneezing, fever, sore throat, headache, and wheezing. Symptoms of severe respiratory syncytial virus infection may also include fever; severe cough; wheezing; short, shallow, and rapid breathing or difficulty breathing; bluish skin; poor appetite; extreme fatigue; and irritability.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Respiratory Syncytial Virus (RSV) Infection?
Treatment for respiratory syncytial virus infection is focused on supportive and self-care, including over-the-counter pain medications, such as acetaminophen; saline nasal drops; cough medicine; and fluids. (Note that children should never be given aspirin. In addition, children under four years of age should not be given cough medicine unless prescribed by a physician.) Antibiotics may be prescribed if bacterial pneumonia develops. Patients with severe respiratory syncytial virus infection are treated in the hospital. In-hospital treatment for patients with severe respiratory syncytial virus infection may include intravenous fluids, antibiotics, humidified oxygen, intubation, and mechanical ventilation.
Who are the top Respiratory Syncytial Virus (RSV) Infection Local Doctors?
Experienced in Respiratory Syncytial Virus (RSV) Infection
Dr. Matthew W. Mccauley
Internal Medicine
Experienced in Respiratory Syncytial Virus (RSV) Infection
Dr. Matthew W. Mccauley
Internal Medicine

Milford Regional Physician Group, Inc.

14 Prospect St, 
Milford, MA 
 (0.8 mi)
508-422-2305
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Matthew Mccauley is an Internal Medicine provider in Milford, Massachusetts. Dr. Mccauley and is rated as an Experienced provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. His top areas of expertise are Familial Neurocardiogenic Syncope, Heart Failure with Preserved Ejection Fraction (HFpEF), Lung Metastases, Endoscopy, and Ureteroscopy. Dr. Mccauley is currently accepting new patients.

Experienced in Respiratory Syncytial Virus (RSV) Infection
Dr. Ashley E. Butland
Internal Medicine | Hospital Medicine
Experienced in Respiratory Syncytial Virus (RSV) Infection
Dr. Ashley E. Butland
Internal Medicine | Hospital Medicine

Milford Regional Physician Group, Inc.

14 Prospect St, 
Milford, MA 
 (0.8 mi)
508-422-2305
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Ashley Butland is a Hospital Medicine provider in Milford, Massachusetts. Dr. Butland and is rated as an Experienced provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. Her top areas of expertise are Liver Failure, Respiratory Syncytial Virus (RSV) Infection, Gallbladder Disease, Endoscopy, and Colonoscopy. Dr. Butland is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Respiratory Syncytial Virus (RSV) Infection
Dr. Kathleen M. Aras-Richard
Pulmonary Medicine | Intensive Care Medicine
Experienced in Respiratory Syncytial Virus (RSV) Infection
Dr. Kathleen M. Aras-Richard
Pulmonary Medicine | Intensive Care Medicine

Milford Regional Physician Group, Inc.

94 Mendon St, 
Hopedale, MA 
 (1.3 mi)
508-482-5401
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kathleen Aras-Richard is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Hopedale, Massachusetts. Dr. Aras-Richard and is rated as an Experienced provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. Her top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Pneumonia, Endoscopy, and Gastrostomy. Dr. Aras-Richard is currently accepting new patients.

View All Doctors
What are the latest Respiratory Syncytial Virus (RSV) Infection Clinical Trials?
Respiratory Syncytial Virus Infection in Exacerbations of Chronic Obstructive Pulmonary Diasease: the RECODE Study
Respiratory Syncytial Virus Infection in Exacerbations of Chronic Obstructive Pulmonary Diasease: the RECODE Study
Enrollment Status: Recruiting
Publish Date: February 26, 2025

Summary: The goal of this observational study is to determine the prevalence of respiratory syncytial virus (RSV) infection and evaluate its association with clinical outcomes in patients with chronic obstructive pulmonary disease (COPD) who experience exacerbations during the RSV season (October-April). The main question it aims to answer is: * What is the prevalence of RSV infection in patients with COPD...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Randomized, Double-blind, Placebo-controlled, Phase III Confirmatory Study to Evaluate the Efficacy, Safety, Tolerability, and Antiviral Activity of Repeated Oral Administration of AK0529 in Hospitalized Infants with Respiratory Syncytial Virus Infection
A Randomized, Double-blind, Placebo-controlled, Phase III Confirmatory Study to Evaluate the Efficacy, Safety, Tolerability, and Antiviral Activity of Repeated Oral Administration of AK0529 in Hospitalized Infants with Respiratory Syncytial Virus Infection
Enrollment Status: Recruiting
Publish Date: January 15, 2025
Intervention Type: Drug
Study Phase: Phase 3

Summary: Respiratory syncytial virus (RSV) is the most common respiratory infectious pathogen recognized worldwide that poses serious health risks to infants, and an important cause of hospitalization for severe respiratory infections in infants. Serious respiratory problems such as pneumonia caused by RSV are one of the leading causes of death from respiratory diseases in infants. AK0529 targets the Pre-F...

View All Clinical Trials